Get Published in Human Gene Therapy

Get Published in Human Gene Therapy

All accepted abstracts from ICLE 2023 would be published in

Human Gene Therapy

(Impact Factor 4.793*)

*2021 Journal Citation Reports™ (Clarivate, 2022)

CiteScore™: 8.2


Human Gene Therapy is the premier, multidisciplinary journal covering all aspects of gene therapy. The Journal publishes in-depth coverage of DNA, RNA, and cell therapies by delivering the latest breakthroughs in research and technologies. Human Gene Therapy provides a central forum for scientific and clinical information, including ethical, legal, regulatory, social, and commercial issues, which enables the advancement and progress of therapeutic procedures leading to improved patient outcomes, and ultimately, to curing diseases.

Visit website

To view all ICLE 2022 published abstracts, please click on the cover below:

ICLE 2022 Abstracts

Pages: A-1–A-42

Published Online: 30 March 2022

Editor-in-Chief: Terence R. Flotte, MD
Deputy Editor-in-Chief: Guangping Gao, PhD
European Editor: Hildegard Büning, PhD
Asian Editor: Yu-Quan Wei MD, PhD
Deputy Editors: Mark Kay, MD, PhD, Thierry VandenDriessche, PhD, and Cheng Seng, PhD